SBI Securities’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45 Hold
40
– – ﹤0.01% 3758
2026
Q2
$49 Hold
40
– – ﹤0.01% 3676
2026
Q1
$28 Hold
40
– – ﹤0.01% 3694
2025
Q4
$62 Hold
40
– – ﹤0.01% 3536
2025
Q3
$63 Hold
40
– – ﹤0.01% 3644
2025
Q2
$87 Buy
40
+10
+33% +$24 ﹤0.01% 3580
2025
Q1
$82 Buy
+30
New +$118 ﹤0.01% 3509

Other funds holding MXCT

SBI Securities's MXCT Position: Q3 2026 in Review

SBI Securities held its MaxCyte (MXCT) position steady in Q3 2026 at 40 shares worth $45. The position accounts for ﹤0.01% of the portfolio, ranked #3758.

SBI Securities first reported a position in MXCT in Q1 2025 and has held it in 7 quarters since. The position peaked at $87 in Q2 2025. 12 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • SBI Securities held 40 shares of MaxCyte worth $45 as of Q3 2026.
  • SBI Securities left its MaxCyte share count unchanged in Q3 2026.
  • MaxCyte made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3758 holding.
  • SBI Securities first reported a position in MaxCyte in Q1 2025 and has held it in 7 quarters since.
  • SBI Securities's MaxCyte position peaked at $87 in Q2 2025.
  • 12 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.